Tissue Engineering And Nanotheranostics

b2815 Tissue Engineering and Nanotheranostics “9.61x6.69”

256 Tissue Engineering and Nanotheranostics

28. Khaliq NU, Sandra FC, Park DY, Lee JY, Oh KS, Kim D, Byun Y, Kim
    IS, Kwon IC, Kim SY, Yuk SH. Doxorubicin/heparin composite nano­
    particles for caspase­activated prodrug chemotherapy. Biomatrials 101 ,
    131–142 (2016).


29. Li M, Luo Z, Zhao Y. Hybrid nanoparticles as drug carriers
    for controlled chemotherapy of cancer. Chemical. Record 16 ,
    1833–1851 (2016).


30. Li SY, Sun R, Wang HX, Shen S, Liu Y, Du XJ, Zhu YH, Jun W.
    Combination therapy with epigenetic­targeted and chemotherapeutic
    drugs delivered by nanoparticles to enhance the chemotherapy
    response and overcome resistance by breast cancer stem cells.
    J. Control. Release 205 , 7–14 (2015).


31. Alexiou A, Vairaktarakis C, Tsiamis V, Ashraf GM. Application of effi­
    cient nanoparticles for early diagnosis and treatment of cancer. Curr.
    Drug Metab. 16 , 662–675 (2015).


32. Zhang C, Yan Y, Zou Q, Chen J, Li C. Superparamagnetic iron oxide
    nanoparticles for MR imaging of pancreatic cancer: Potential for early
    diagnosis through targeted strategies. Asia Pac. J. Clini. Oncol. 12 ,
    13–21 (2016).


33. Laurentius LB, Owens NA, Park J, Crawford AC, Porter MD.
    Advantages and limitations of nanoparticle labeling for early diagnosis
    of infection. Expert Rev. Mol. Diagn. 16 , 883–895 (2016).


34. Cho H, Yeh EC, Sinha R, Laurence TA, Bearinger JP, Lee LP. Single­
    step nanoplasmonic VEGF165 aptasensor for early cancer diagnosis.
    ACS Nano. 6 , 7607–7614 (2012).


35. Cheng K, Cheng Z. Near infrared receptor­targeted nanoprobes for
    early diagnosis of cancers. Curr. Med. Chem. 19 , 4767–4785
    (2012).


36. Xifre­Perez E, Guaita­Esteruelas S, Baranowska M, Pallares J,
    Masana L, Marsal LF. In vitro biocompatibility of surface­modified
    porous alumina particles for hepg2 tumor cells: Toward early diag­
    nosis and targeted treatment. ACS. Appl. Mater. Int. 7 , 18600–
    18608 (2015).


37. Wallnofer EA, Thurner GC, Abdelmoez AA, Rohr I, Klammsteiner N,
    Talasz H, Kremser C, Jaschke W, Debbage P. MRI molecular imaging
    with nanoparticles: A Technical platform for early diagnosis of cancer.
    Int. J. Clin. Pharmacol. Ther. 49 , 73–74 (2011).


38. Jia Z, Song L, Zang F, Song J, Zhang W, Yan C, Xie J, Ma Z, Ma M,
    Teng G, Gu N, Zhang Y. Active­target T1­weighted MR imaging of tiny